BackgroundThe importance of sleep is paramount to health. Insufficient sleep can reduce physical, emotional, and mental well-being and can lead to a multitude of health complications among people with chronic conditions. Physical activity and sleep are highly interrelated health behaviors. Our physical activity during the day (ie, awake time) influences our quality of sleep, and vice versa. The current popularity of wearables for tracking physical activity and sleep, including actigraphy devices, can foster the development of new advanced data analytics. This can help to develop new electronic health (eHealth) applications and provide more insights into sleep science.ObjectiveThe objective of this study was to evaluate the feasibility of predicting sleep quality (ie, poor or adequate sleep efficiency) given the physical activity wearable data during awake time. In this study, we focused on predicting good or poor sleep efficiency as an indicator of sleep quality.MethodsActigraphy sensors are wearable medical devices used to study sleep and physical activity patterns. The dataset used in our experiments contained the complete actigraphy data from a subset of 92 adolescents over 1 full week. Physical activity data during awake time was used to create predictive models for sleep quality, in particular, poor or good sleep efficiency. The physical activity data from sleep time was used for the evaluation. We compared the predictive performance of traditional logistic regression with more advanced deep learning methods: multilayer perceptron (MLP), convolutional neural network (CNN), simple Elman-type recurrent neural network (RNN), long short-term memory (LSTM-RNN), and a time-batched version of LSTM-RNN (TB-LSTM).ResultsDeep learning models were able to predict the quality of sleep (ie, poor or good sleep efficiency) based on wearable data from awake periods. More specifically, the deep learning methods performed better than traditional linear regression. CNN had the highest specificity and sensitivity, and an overall area under the receiver operating characteristic (ROC) curve (AUC) of 0.9449, which was 46% better as compared with traditional linear regression (0.6463).ConclusionsDeep learning methods can predict the quality of sleep based on actigraphy data from awake periods. These predictive models can be an important tool for sleep research and to improve eHealth solutions for sleep.

Accurately measuring sleep and its quality with polysomnography (PSG) is an expensive task. Actigraphy, an alternative, has been proven cheap and relatively accurate. However, the largest experiments conducted to date, have had only hundreds of participants. In this work, we processed the data of the recently published Multi-Ethnic Study of Atherosclerosis (MESA) Sleep study to have both PSG and actigraphy data synchronized. We propose the adoption of this publicly available large dataset, which is at least one order of magnitude larger than any other dataset, to systematically compare existing methods for the detection of sleep-wake stages, thus fostering the creation of new algorithms. We also implemented and compared state-of-the-art methods to score sleep-wake stages, which range from the widely used traditional algorithms to recent machine learning approaches. We identified among the traditional algorithms, two approaches that perform better than the algorithm implemented by the actigraphy device used in the MESA Sleep experiments. The performance, in regards to accuracy and F 1 score of the machine learning algorithms, was also superior to the device’s native algorithm and comparable to human annotation. Future research in developing new sleep-wake scoring algorithms, in particular, machine learning approaches, will be highly facilitated by the cohort used here. We exemplify this potential by showing that two particular deep-learning architectures, CNN and LSTM, among the many recently created, can achieve accuracy scores significantly higher than other methods for the same tasks.

No abstract

Childhood epilepsy with centrotemporal spikes, previously known as Benign Epilepsy with Centro-temporal Spikes (BECTS) or Rolandic Epilepsy, is one of the most common forms of focal childhood epilepsy. Despite its prevalence, BECTS is often misdiagnosed or missed entirely. This is in part due to the nocturnal and brief nature of the seizures, making it difficult to identify during a routine electroencephalogram (EEG). Detecting brain activity that is highly associated with BECTS on a brief, awake EEG has the potential to improve diagnostic screening for BECTS and predict clinical outcomes. For this study, 31 patients with BECTS were retrospectively selected from the BCH Epilepsy Center database along with a contrast group of 31 patients in the database who had no form of epilepsy and a normal EEG based on a clinical chart review. Nonlinear features, including multiscale entropy and recurrence quantitative analysis, were computed from 30-second segments of awake EEG signals. Differences were found between these multiscale nonlinear measures in the two groups at all sensor locations, while visual EEG inspection by a board-certified child neurologist did not reveal any distinguishing features. Moreover, a quantitative difference in the nonlinear measures (sample entropy, trapping time and the Lyapunov exponents) was found in the centrotemporal region of the brain, the area associated with a greater tendency to have unprovoked seizures, versus the rest of the brain in the BECTS patients. This difference was not present in the contrast group. As a result, the epileptic zone in the BECTS patients appears to exhibit lower complexity, and these nonlinear measures may potentially serve as a clinical screening tool for BECTS, if replicated in a larger study population.

No abstract

Abstract-Human Activity Recognition (HAR) is a powerful tool for understanding human behaviour. Applying HAR to wearable sensors can (1) provide new insights by enriching the feature set in health studies, and (2) enhance the personalisation and effectiveness of health, wellness, and fitness applications. Wearable devices provide an unobtrusive platform for user monitoring, and due to their increasing market penetration, feel intrinsic to the wearer. The integration of these devices in daily life provide a unique opportunity for understanding human health and wellbeing. This is referred to as the "quantified self" movement.The analyses of complex health behaviours such as sleep, traditionally require a time-consuming manual interpretation by experts. This manual work is necessary due to the erratic periodicity and persistent noisiness of human behaviour. In this paper, we present a robust automated human activity recognition algorithm, which we call RAHAR. We test our algorithm in the application area of sleep research by providing a novel framework for evaluating sleep quality and examining the correlation between the aforementioned and an individual's physical activity. Our results improve the state-of-the-art procedure in sleep research by 15% for area under ROC and by 30% for F1 score on average. However, application of RAHAR is not limited to sleep analysis and can be used for understanding other health problems such as obesity, diabetes, and cardiac diseases.

Purpose: Evaluating the effects of antiseizure medication (ASM) on patients with epilepsy remains a slow and challenging process. Quantifiable noninvasive markers that are measurable in real-time and provide objective and useful information could guide clinical decision-making. We examined whether the effect of ASM on patients with epilepsy can be quantitatively measured in real-time from EEGs.Methods: This retrospective analysis was conducted on 67 patients in the long-term monitoring unit at Boston Children's Hospital. Two 30-second EEG segments were selected from each patient premedication and postmedication weaning for analysis. Nonlinear measures including entropy and recurrence quantitative analysis values were computed for each segment and compared before and after medication weaning.Results: Our study found that ASM effects on the brain were measurable by nonlinear recurrence quantitative analysis on EEGs. Highly significant differences (P , 1e-11) were found in several nonlinear measures within the seizure zone in response to antiseizure medication. Moreover, the size of the medication effect correlated with a patient's seizure frequency, seizure localization, number of medications, and reported seizure frequency reduction on medication.Conclusions: Our findings show the promise of digital biomarkers to measure medication effects and epileptogenicity.

No abstract